Skip to content

Clinical trials

Muscular Dystrophies trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Muscular Dystrophies Country / region: Netherlands Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20102
20111
20121
20151
20171
20181
20191
20201
20211
20221
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated5
Active, not recruiting2
Enrolling by invitation1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline3
Fulcrum Therapeutics2
Vertex Pharmaceuticals Incorporated2
Avidity Biosciences, Inc.1
BioMarin Pharmaceutical1
Hoffmann-La Roche1
Kyntra Bio1
Maastricht University1
University Medical Center Nijmegen1
University of Kansas Medical Center1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Muscular Dystrophies14
Muscular Dystrophy, Duchenne7
Musculoskeletal Diseases6
Neuromuscular Diseases6
Muscular Diseases5
Genetic Diseases, Inborn4
Muscular Disorders, Atrophic4
Nervous System Diseases4
Muscular Dystrophy, Facioscapulohumeral3
Myotonic Dystrophy3

Trials

Showing 76 to 14 of 14. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.